(19)
(11) EP 4 770 614 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24772168.1

(22) Date of filing: 28.08.2024
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 47/26(2006.01)
A61K 9/51(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0043; A61K 9/0078; A61K 9/5123; A61K 47/26
(86) International application number:
PCT/US2024/044193
(87) International publication number:
WO 2025/049579 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 31.08.2023 US 202363628884 P

(71) Applicant: Global Life Sciences Solutions Canada ULC
Vancouver, British Columbia V6A 3P4 (CA)

(72) Inventors:
  • SADAT, Sams Mohammad Anowar
    Vancouver, British Columbia V6P 6T7 (CA)
  • THOMAS, Anitha
    Vancouver, British Columbia V6P 6T7 (CA)

(74) Representative: Bannan, Sally 
Cytiva Amersham Place Little Chalfont
Buckinghamshire HP7 9NA
Buckinghamshire HP7 9NA (GB)

   


(54) INTRANASAL FORMULATION FOR PULMONARY DELIVERY OF NANOPARTICLES, COMPOSITIONS, USES, AND MANUFACTURING METHODS THEREOF